v3.24.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Net revenue | $ 1,282,089 | $ 1,162,801 | $ 2,506,598 | $ 2,265,122 |
| Cost of sales (exclusive of amortization shown separately below) | 523,180 | 507,610 | 1,022,800 | 1,000,964 |
| Amortization of acquired intangible assets | 7,634 | 8,257 | 15,304 | 17,164 |
| Total cost of sales | 530,814 | 515,867 | 1,038,104 | 1,018,128 |
| Gross profit | 751,275 | 646,934 | 1,468,494 | 1,246,994 |
| Operating Expenses | ||||
| Selling, general, and administrative | 241,613 | 222,155 | 480,592 | 445,029 |
| Research and development | 81,372 | 73,880 | 160,897 | 149,590 |
| Amortization of acquired intangible assets | 11,047 | 11,577 | 22,451 | 24,056 |
| Restructuring expenses (note 11) | 0 | 64,228 | 0 | 64,228 |
| Total operating expenses | 334,032 | 371,840 | 663,940 | 682,903 |
| Income from operations | 417,243 | 275,094 | 804,554 | 564,091 |
| Other income (loss), net: | ||||
| Interest (expense) income, net | (775) | (13,805) | (2,436) | (28,762) |
| Gain (loss) attributable to equity method investments (note 5) | 1,077 | 739 | 2,040 | (3,156) |
| Gain (loss) on equity investments (note 5) | (1,439) | (1,888) | (2,119) | (2,491) |
| Other, net | 2,216 | (686) | (219) | 1,963 |
| Total other income (loss), net | 1,079 | (15,640) | (2,734) | (32,446) |
| Income before income taxes | 418,322 | 259,454 | 801,820 | 531,645 |
| Income taxes | 73,700 | 50,654 | 145,843 | 103,423 |
| Net income | $ 344,622 | $ 208,800 | $ 655,977 | $ 428,222 |
| Basic earnings per share (in dollars per share) | $ 2.35 | $ 1.42 | $ 4.47 | $ 2.91 |
| Diluted earnings per share (in dollars per share) | 2.34 | 1.42 | 4.45 | 2.90 |
| Dividend declared per share (in dollars per share) | $ 0.53 | $ 0.48 | $ 1.06 | $ 0.96 |
| Basic shares outstanding (000's) (in shares) | 146,810 | 147,132 | 146,835 | 147,104 |
| Diluted shares outstanding (000's) (in shares) | 147,481 | 147,545 | 147,520 | 147,572 |
| Total Sleep and Breathing Health | ||||
| Net revenue | $ 1,125,593 | $ 1,017,855 | $ 2,193,330 | $ 1,980,892 |
| Cost of sales (exclusive of amortization shown separately below) | 473,388 | 460,721 | 924,700 | 905,182 |
| Amortization of acquired intangible assets | 1,230 | 1,324 | 2,440 | 3,240 |
| Residential Care Software | ||||
| Net revenue | 156,496 | 144,946 | 313,268 | 284,230 |
| Cost of sales (exclusive of amortization shown separately below) | 49,792 | 46,889 | 98,100 | 95,782 |
| Amortization of acquired intangible assets | $ 6,404 | $ 6,933 | $ 12,864 | $ 13,924 |
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of acquired intangible assets. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate dividends declared during the period for each share of common stock outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|